Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

news.google.com

Biocon Biosimilar - Google News

Get the latest updates from Biocon Biosimilar - Google News directly as they happen.

Follow now < 10 followers

Latest posts

Last updated about 5 hours ago

EC approves Biocon Biologics’ denosumab biosimilars - The Pharma Letter

about 21 hours ago

EC approves Biocon Biologics’ denosumab biosimilars  The Pharma Letter

Pegfilgrastim Biosimilars Market Exclusive Report with - openPR.com

1 day ago

Pegfilgrastim Biosimilars Market Exclusive Report with  openPR.com

Biocon Biologics gets EU approval for Vevzuo and Evfraxy biosimilars - ET Now

2 days ago

Biocon Biologics gets EU approval for Vevzuo and Evfraxy biosimilars  ET Now

Biocon Biologics gets EU approval for Vevzuo and Evfraxy biosimilars - ET Now

2 days ago

Biocon Biologics gets EU approval for Vevzuo and Evfraxy biosimilars  ET Now

Insulin Biosimilars Market Exclusive Report with Detailed - openPR.com

2 days ago

Insulin Biosimilars Market Exclusive Report with Detailed  openPR.com

Amgen sues Biocon over blockbuster bone drugs as first biosimilars enter market - Life Sciences Intellectual Property Review

2 days ago

Amgen sues Biocon over blockbuster bone drugs as first biosimilars enter market...

Biocon biologics receives European Commission approval for Vevzuo, Evfraxy Denosumab biosimilars for bone - The Economic Times

2 days ago

Biocon biologics receives European Commission approval for Vevzuo, Evfraxy Denosumab biosimilars for...

Advancing Bone Health: European Commission Approves Biocon Biologics' Denosumab Biosimilars - PR Newswire UK

2 days ago

Advancing Bone Health: European Commission Approves Biocon Biologics' Denosumab Biosimilars  PR Newswire...

Advancing Bone Health: European Commission Approves Biocon Biologics' Denosumab Biosimilars - PR Newswire

2 days ago

Advancing Bone Health: European Commission Approves Biocon Biologics' Denosumab Biosimilars  PR Newswire

biocon biologics has received marketing authorisation in europe for vevuzo and evfraxy biosimilars - ICICI Direct

2 days ago

biocon biologics has received marketing authorisation in europe for vevuzo and evfraxy...

Biocon Biologics gets EU approval for 2 drugs to treat bone cancer, osteoporosis and bone loss - financialexpress.com

2 days ago

Biocon Biologics gets EU approval for 2 drugs to treat bone cancer...

Biocon arm gets market authorisation in EU for two biosimilars of Denosumab - CNBC TV18

2 days ago

Biocon arm gets market authorisation in EU for two biosimilars of Denosumab...